In adenocarcinomas, bone morphogenetic protein‐4 (BMP4), one of the tumor‐derived regulatory programs, could augment PD‐L1 expression in the mesenchymal subset of lung cancer cells.57 Here, CD274 is linked to adenocarcinoma.